A Novel Pre-treatment Approach to Ulcerative Colitis in a Mouse Model
Background: Inflammatory Bowel Disease (IBD) is a complex multifactorial disease that includes two Crohn's disease and ulcerative colitis (UC). The UC characterized by inflammation, oxidative stress, and increased intestinal epithelial cell apoptosis. The present study aiming to investigate the...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shiraz University of Medical Sciences
2022-12-01
|
| Series: | Iranian Journal of Colorectal Research |
| Subjects: | |
| Online Access: | https://colorectalresearch.sums.ac.ir/article_48978_574bd07cc79da1b2a4530b738b7ea345.pdf |
| _version_ | 1797804472065327104 |
|---|---|
| author | Vahid Pouresmaeil Amir Hooshang Mohammadpour Vahid Ariabod Atena Pourtaji |
| author_facet | Vahid Pouresmaeil Amir Hooshang Mohammadpour Vahid Ariabod Atena Pourtaji |
| author_sort | Vahid Pouresmaeil |
| collection | DOAJ |
| description | Background: Inflammatory Bowel Disease (IBD) is a complex multifactorial disease that includes two Crohn's disease and ulcerative colitis (UC). The UC characterized by inflammation, oxidative stress, and increased intestinal epithelial cell apoptosis. The present study aiming to investigate the protective potential of a combination of five safety products: Bromelain (BR), Silibinin (SB), Alpha-lipoic acid (ALA), Inulin (IN) and Sodium butyrate (BU) against UC. Methods: Seventy-two male Balb/c mice were divided into 9 groups, and administered for 14 days by a minimum effective dose of BR, SB, ALA, IN, BU or all together (PAC). Mesalazine (MZ) is used to compare the therapeutic effects of the compounds. Colitis was induced by rectal injection of acetic acid (4%) in 12th day. Blood and colon tissue were collected and the expression of inflammatory cytokines, and oxidative stress indices were examined using ELISA methods. The SPSS v.24 was used for data analysis.Results: All the therapeutic groups including BR, IN, BU, ALA, SB separately, partially improved histopathological changes due to colitis, but PAC treatment prior to colitis induction significantly (p<0.001), and more effectively alleviated the extent and intensity of the histological signs of cell damage including inflammation intensity, macroscopic and microscopic colon damage, and improved colitis. A significant decrease in inflammatory cytokines and oxidative stress indices also observed in the group treated with ALA, SB and PAC.Conclusion: This new drug combination (PAC) is more beneficial for the prevention of UC better than MZ that is a usual treatment of UC. |
| first_indexed | 2024-03-13T05:36:43Z |
| format | Article |
| id | doaj.art-95aaf0ca824b431880c5a3b788c1222e |
| institution | Directory Open Access Journal |
| issn | 2783-2430 |
| language | English |
| last_indexed | 2024-03-13T05:36:43Z |
| publishDate | 2022-12-01 |
| publisher | Shiraz University of Medical Sciences |
| record_format | Article |
| series | Iranian Journal of Colorectal Research |
| spelling | doaj.art-95aaf0ca824b431880c5a3b788c1222e2023-06-14T06:41:52ZengShiraz University of Medical SciencesIranian Journal of Colorectal Research2783-24302022-12-0110415015910.30476/acrr.2023.97512.116448978A Novel Pre-treatment Approach to Ulcerative Colitis in a Mouse ModelVahid Pouresmaeil0Amir Hooshang Mohammadpour1Vahid Ariabod2Atena Pourtaji3Department of Biochemistry, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.Department of Pathology, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.Pharmaceutical Research Center, Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.Background: Inflammatory Bowel Disease (IBD) is a complex multifactorial disease that includes two Crohn's disease and ulcerative colitis (UC). The UC characterized by inflammation, oxidative stress, and increased intestinal epithelial cell apoptosis. The present study aiming to investigate the protective potential of a combination of five safety products: Bromelain (BR), Silibinin (SB), Alpha-lipoic acid (ALA), Inulin (IN) and Sodium butyrate (BU) against UC. Methods: Seventy-two male Balb/c mice were divided into 9 groups, and administered for 14 days by a minimum effective dose of BR, SB, ALA, IN, BU or all together (PAC). Mesalazine (MZ) is used to compare the therapeutic effects of the compounds. Colitis was induced by rectal injection of acetic acid (4%) in 12th day. Blood and colon tissue were collected and the expression of inflammatory cytokines, and oxidative stress indices were examined using ELISA methods. The SPSS v.24 was used for data analysis.Results: All the therapeutic groups including BR, IN, BU, ALA, SB separately, partially improved histopathological changes due to colitis, but PAC treatment prior to colitis induction significantly (p<0.001), and more effectively alleviated the extent and intensity of the histological signs of cell damage including inflammation intensity, macroscopic and microscopic colon damage, and improved colitis. A significant decrease in inflammatory cytokines and oxidative stress indices also observed in the group treated with ALA, SB and PAC.Conclusion: This new drug combination (PAC) is more beneficial for the prevention of UC better than MZ that is a usual treatment of UC.https://colorectalresearch.sums.ac.ir/article_48978_574bd07cc79da1b2a4530b738b7ea345.pdfulcerative colitisoxidative stressinflammatory cytokinespreventive drug |
| spellingShingle | Vahid Pouresmaeil Amir Hooshang Mohammadpour Vahid Ariabod Atena Pourtaji A Novel Pre-treatment Approach to Ulcerative Colitis in a Mouse Model Iranian Journal of Colorectal Research ulcerative colitis oxidative stress inflammatory cytokines preventive drug |
| title | A Novel Pre-treatment Approach to Ulcerative Colitis in a Mouse Model |
| title_full | A Novel Pre-treatment Approach to Ulcerative Colitis in a Mouse Model |
| title_fullStr | A Novel Pre-treatment Approach to Ulcerative Colitis in a Mouse Model |
| title_full_unstemmed | A Novel Pre-treatment Approach to Ulcerative Colitis in a Mouse Model |
| title_short | A Novel Pre-treatment Approach to Ulcerative Colitis in a Mouse Model |
| title_sort | novel pre treatment approach to ulcerative colitis in a mouse model |
| topic | ulcerative colitis oxidative stress inflammatory cytokines preventive drug |
| url | https://colorectalresearch.sums.ac.ir/article_48978_574bd07cc79da1b2a4530b738b7ea345.pdf |
| work_keys_str_mv | AT vahidpouresmaeil anovelpretreatmentapproachtoulcerativecolitisinamousemodel AT amirhooshangmohammadpour anovelpretreatmentapproachtoulcerativecolitisinamousemodel AT vahidariabod anovelpretreatmentapproachtoulcerativecolitisinamousemodel AT atenapourtaji anovelpretreatmentapproachtoulcerativecolitisinamousemodel AT vahidpouresmaeil novelpretreatmentapproachtoulcerativecolitisinamousemodel AT amirhooshangmohammadpour novelpretreatmentapproachtoulcerativecolitisinamousemodel AT vahidariabod novelpretreatmentapproachtoulcerativecolitisinamousemodel AT atenapourtaji novelpretreatmentapproachtoulcerativecolitisinamousemodel |